Generic Intravenous Amisulpride (QLG2069) for the Prevention of Postoperative Nausea and Vomiting in Adults: A Phase III, Multicenter, Randomized, Placebo-Controlled Study.

Drug Des Devel Ther · 2025 · PMC12414449 · PMID 40923005

Europe PMC DOI

hedged sentence

0.0685

closest p · 1.4× alpha

0.0685

boldest claim

The sentences

did not reach statistical significanceP=0.0685so close (0.05 < p ≤ 0.1)

The proportion of patients without nausea was numerically higher (45.09%) in the amisulpride group compared to that in the placebo group (37.45%), although the difference did not reach statistical significance (P=0.0685).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.